Chidamide improves gefitinib treatment outcomes in NSCLC by attenuating recruitment and immunosuppressive function of myeloid-derived suppressor cells
- Resource Type
- Article
- Source
- In
Biomedicine & Pharmacotherapy April 2024 173 - Subject
- Language
- ISSN
- 0753-3322